SPLENECTOMY PROMOTES POST-TRANSPLANT HEMATOPOIETIC STEM CELL HOMING IN PATIENTS WITH MYELOFIBROSIS BY RESTORING CXCL12 CONCENTRATION GRADIENT

EHA Library, Yi Liao, 4210051

SEX-SPECIFIC DIFFERENCES IN RESPONSE TO RUXOLITINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA TREATED IN THE RANDOMIZED PHASE 2B RUXO-BEAT CLINICAL TRIAL

EHA Library, Steffen Koschmieder, 4210052

REAL-WORLD CHARACTERISTICS, TREATMENT PATTERNS, AND SURVIVAL IN PATIENTS WITH MYELOFIBROSIS AND THOSE USING RUXOLITINIB: A NATIONWIDE STUDY STRATIFIED BY BASELINE AND EARLY TRANSFUSION STATUS

EHA Library, Sin-Syue Li, 4210053

DIAGNOSIS, DISEASE BURDEN, AND TREATMENT IN ESSENTIAL THROMBOCYTHEMIA: A COMPARATIVE QUALITATIVE STUDY OF CLINICIAN AND PATIENT PERSPECTIVES IN THE UNITED STATES

EHA Library, Martin Paczkowski, 4210054

REAL WORLD HAEMATOLOGICAL OUTCOMES FOLLOWING TRANSITION TO ROPEGINTERFERON ALFA-2B DURING PEGYLATED INTERFERON SHORTAGE

EHA Library, Llywelyn Cadman-Davies, 4210056

EHA GUIDELINE ON THE DIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMS IN PATIENTS AGED 25 YEARS OR YOUNGER: INTEGRATING BEST AVAILABLE EVIDENCE IN A RARE DISEASE SETTING

EHA Library, Julia Schroer, 4210057

PHASE 2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF BOMEDEMSTAT (IMG-7289) IN COMBINATION WITH MOMELOTINIB IN PATIENTS WITH MYELOFIBROSIS

EHA Library, Ciro Rinaldi, 4210058

BASELINE CHARACTERISTICS AT DIAGNOSIS IN CHINESE MYELOFIBROSIS PATIENTS: A CROSS-SECTIONAL STUDY (CHAMPION-001)

EHA Library, Zefeng Xu, 4210059

MULTI-CENTER REAL WORLD ANALYSIS OF EFFICACY AND SAFETY OF GECACITINIB IN THE TREATMENT OF MYELOFIBROSIS

EHA Library, Chen Cao, 4210060

LONG-TERM FOLLOW-UP OF A SERIES OF 165 POLYCYTHEMIA VERA PATIENTS FROM A SINGLE CENTER

EHA Library, Evangelia-Faidra Triantafyllou, 4210061

PRELIMINARY DATA ON SERUM OSTEOPROTEGERIN AND RANKL LEVELS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (MPNS)

EHA Library, Annita-Ioanna Gkioka, 4210062

UTILITY OF NEXT-GENERATION SEQUENCING (NGS) IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Concepción Sánchez Chamizo, 4210063

SYSTEM-WIDE VARIABILITY IN SECONDARY POLYCYTHEMIA MANAGEMENT: A NATIONWIDE ENTROPY-BASED ANALYSIS

EHA Library, Sinan Mersin, 4210064

EXPLORATORY MACHINE LEARNING–BASED IDENTIFICATION OF PREDICTORS OF DISEASE PROGRESSION AND MORTALITY IN POLYCYTHEMIA VERA

EHA Library, Giulia Benevolo, 4210065

ASSOCIATION BETWEEN JAK2V617F ALLELE BURDEN, CLINICAL FORMS, AND THROMBOEMBOLIC RISK GROUPS IN POLYCYTHEMIA VERA.

EHA Library, Fidan Khalilova, 4210066

REAL LIFE OUTCOME OF MOMELOTINIB IN PATIENTS  WITH PRIMARY OR SECONDARY MYELOFIBROSIS: PRELIMINARY RESULTS OF A RETROSPECTIVE EXPERIENCE OF TWO PUGLIA CENTERS

EHA Library, Anna Mele, 4210067

EFFECTS OF LONG-TERM HYDROXYUREA THERAPY ON BONE MARROW MEGAKARYOCYTE MORPHOLOGY AND ITS CORRELATION WITH PROGNOSIS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA

EHA Library, Jian Huang, 4210070

IMPACT OF BONE RESORPTIVE INHIBITORS ON DISEASE, SKELETAL, AND TREATMENT-RELATED OUTCOMES IN HISTIOCYTIC DISORDERS

EHA Library, Katherine Chapis, 4210072

CLINICAL AND MOLECULAR CHARACTERISTICS AND PROGNOSTIC ANALYSIS OF ADULT POLYCYTHEMIA VERA: A MULTI-CENTER COHORT STUDY

EHA Library, Jian Huang, 4210073

AGE AS A PROGNOSTIC FACTOR IN ADULT POLYCYTHEMIA VERA: A MULTICENTER REAL-WORLD STUDY

EHA Library, Jian Huang, 4210074

REAL-WORLD (RW) CHART REVIEW OF CYTOREDUCTIVE THERAPY (CRT) PATTERNS, ADVERSE EVENTS AND TREATMENT MODIFICATIONS IN POLYCYTHEMIA VERA (PV) ACROSS PHYSICIAN PRACTICE SETTINGS IN THE US

EHA Library, Naveen Pemmaraju, 4210075

WHOLE-EXOME SEQUENCING IN JAK2 UNMUTATED ERYTHROCYTOSIS: A STUDY OF A COHORT FROM A TERTIARY REFERENCE HOSPITAL

EHA Library, Ningning Liu, 4210076

NEUTROPHIL-TO-LYMPHOCYTE RATIO AS AN INFLAMMATORY MARKER IN POLYCYTHEMIA VERA PATIENTS TREATED WITH ROPEGINTERFERON ALFA-2B

EHA Library, Bianca Nistor, 4210077

BEYOND DONATION: HARNESSING ROUTINE CBCS FOR EARLY DETECTION OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Juan Pablo Macías Flores, 4210078

DESIGN VERIFICATION TESTING OF A HIGHLY SENSITIVE MULTIPLEX QPCR ASSAY THAT DETECTS THE JAK2 V617F VARIANT COMMONLY PRESENT IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Jonathan Turner, 4210079

REAL WORLD DATA ON SAFETY AND EFFICACY OF ROPEGINTERFERON ALPHA-2B FOR THE TREATMENT OF POLYCYTHEMIA VERA

EHA Library, Thomas Thomopoulos, 4210080

CO-DESIGN OF A DIGITAL RESOURCE FOR PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM ASSOCIATED SPLANCHNIC VEIN THROMBOSIS (MPN-SVT) AND CLINICIANS INVOLVED IN THEIR CARE

EHA Library, Mallika Sekhar, 4210081

TREATMENT DISRUPTION DURING THE INTERNATIONAL PEGYLATED INTERFERON SHORTAGE: RESULTS OF AN INTERNATIONAL PATIENT SURVEY IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Llywelyn Cadman-Davies, 4210082

A PHASE 2/3 STUDY OF ELENESTINIB IN ISM: A TRIAL-IN-PROGRESS UPDATE OF NOVEL ENDPOINTS AND BIOMARKERS AIMED AT EVALUATING DISEASE MODIFICATION (HARBOR)

EHA Library, Jens Panse, 4210083

VALIDATION OF TRIPLE A SCORE IN POLYCITEMIA VERA IN A SINGLE PORTUGUESE CENTER

EHA Library, Maria Inês Pinto, 4210084

DOES HAPLOIDENTICAL TRANSPLANTATION IMPROVE MYELOFIBROSIS OUTCOMES IN REAL-WORLD? A SINGLE-CENTER EXPERIENCE FROM THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM

EHA Library, Lucas Sales, 4210085

UNMASKING DIABETES MELLITUS IN PATIENTS WITH BCR::ABL1 NEGATIVE MYELOPROLIFERATIVE NEOPLASMS USING CONTINUOUS GLUCOSE MONITORING

EHA Library, Josipa Budimir, 4210086

CLINICAL OUTCOMES OF MOMELOTINIB IN A REAL-WORLD COHORT OF PATIENTS WITH MYELOFIBROSIS

EHA Library, Esther Ortega Vida, 4210087

CORRELATION OF MEGAKARYOCYTE MORPHOLOGY WITH ADVERSE PROGNOSIS IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Jian Huang, 4210088

DIAGNOSTIC AND THERAPEUTIC INEQUITIES IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: A MULTINATIONAL LATIN AMERICAN PHYSICIAN SURVEY

EHA Library, Carlos Murilo Barbosa Junior, 4210089

DEVELOPMENT OF EXPERT CONSENSUS ON THE MANAGEMENT OF MYELOFIBROSIS PATIENTS WITH ANAEMIA AND/OR THROMBOCYTOPENIA: A MODIFIED DELPHI PANEL

EHA Library, Gabriela Hobbs, 4210090

MORTALITY AND OUTCOMES AFTER CARDIOPULMONARY RESUSCITATION AND AFTER INTENSIVE CARE IN SWEDISH MYELOPROLIFERATIVE NEOPLASM PATIENTS

EHA Library, Helna Pettersson, 4210091

DISPARITIES IN TREATMENT MANAGEMENT AND OUTCOMES OF WHITE AND NON-WHITE ADOLESCENTS AND YOUNG ADULTS WITH MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Shruti Gajjar, 4210092

PRESENTATION AND MANAGEMENT OF PRIMARY MYELOFIBROSIS IN AZERBAIJAN: A RETROSPECTIVE NATIONAL CENTRE ANALYSIS

EHA Library, Elmir GULUYEV, 4210093

LANGERHANS CELL HISTIOCYTOSIS AND OTHER HISTIOCYTOSIS: A SINGLE CENTRE EXPERIENCE

EHA Library, Marianna Criscuolo, 4210094

PREVALENCE OF THROMBOSIS AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH POLYCYTHAEMIA VERA; A MULTI CENTRE DESCRIPTIVE ANALYTICAL STUDY IN THE WESTERN PROIVINCE OF SRI LANKA

EHA Library, Ahalyaa Sivashangar, 4210095

SENTRY2—A PHASE II STUDY EVALUATING SELINEXOR MONOTHERAPY IN PATIENTS WITH JAKI-NAÏVE MYELOFIBROSIS AND MODERATE THROMBOCYTOPENIA

EHA Library, Joseph M Scandura, 4210096

DEMOGRAPHIC, CLINICAL CHARACTERISTICS OF BCR/ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS PATIENTS IN OMAN, SINGLE CENTER EXPERIENCE

EHA Library, Zahra ALGhammari, 4210097

THE RATIONALE FOR THE ROUTINE USAGE OF NEXT GENERATION SEQUENCING (NGS) METHOD FOR DETECTION OF ADDITIONAL MUTATIONS IN ESSENTIAL THROMBOCYTHEMIA PATIENTS-SINGLE CENTRE EXPERIENCE

EHA Library, Marija Popova Labachevska, 4210098

MOLECULAR REMISSION IN THE TREATMENT OF POLYCYTHEMIA VERA: SHORT-TERM EFFECT OF ROPEGINTERFERON ALFA2-B

EHA Library, Veronica Vecchio, 4210099

REAL-WORLD OUTCOMES OF MYELOFIBROSIS IN AN UNDERREPRESENTED LATIN AMERICAN POPULATION: EARLY EXPERIENCE FROM THE HOSPITAL GENERAL DE MÉXICO DR. EDUARDO LICEAGA

EHA Library, Gilberto Israel Barranco Lampon, 4210100

SAFETY AND EFFICACY OF RUXOLITINIB TREATMENT IN PATIENTS WITH MYELOFIBROSIS - A SINGLE-CENTER EXPERIENCE

EHA Library, Petra Belohlavkova, 4210101

REAL WORLD OUTCOMES OF TREATMENT WITH RUXOLITINIB FOR POLYCYTHAEMIA VERA PATIENTS AT A SINGLE CENTRE DISTRICT GENERAL HOSPITAL

EHA Library, Tanveer Hamid, 4210102

JAK2-POSITIVE HYPEREOSINOPHILIC SYNDROME PRESENTING WITH VASCULAR AND GI
COMPLICATIONS

EHA Library, Rogermar VIllanueva, 4210103

ACUTE CORONARY SYNDROME IN ESSENTIAL THROMBOCYTHEMIA: A CASE SERIES AND CLINICAL INSIGHTS

EHA Library, Marta Hernández Durán, 4210104

DEEP LEARNING-ENHANCED BASELINE PET FOR PROGNOSTIC PREDICTION IN CLASSICAL HODGKIN LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Jingyan Xu, 4210106

FROM LONG‑TERM BENEFIT TO RISK‑STRATIFIED MANAGEMENT: A 5‑YEAR REAL‑WORLD MULTICENTER STUDY OF PD‑1 INHIBITORS IN CHINESE RELAPSED/REFRACTORY HODGKIN LYMPHOMA

EHA Library, Wenyan Yu, 4210107

FRONTLINE THERAPY AND OUTCOMES OF CLASSICAL HODGKIN LYMPHOMA IN MALAYSIA: A NATIONWIDE MULTICENTRE REAL-WORLD COHORT

EHA Library, Yang Liang Boo, 4210108

NODULAR LYMPHOCYTE PREDOMINANT HODGKIN'S LYMPHOMA WITH TRANSFORMATION TO DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Dorokhina, 4210109

LUNG FUNCTION ASSESSMENT BY DIFFUSING CAPACITY OF THE LUNGS FOR CARBON MONOXIDE (DLCO) MEASUREMENT IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA RECEIVING FIRST-LINE TREATMENT WITH NIVOLUMAB-AVD

EHA Library, Athanasios Liaskas, 4210111

GENOMIC INSTABILITY IN CLASSICAL HODGKIN LYMPHOMA: ASSOCIATION WITH METABOLIC TUMOR BURDEN AND CIRCULATING TUMOR DNA DETECTABILITY.

EHA Library, Anna Kravtsova, 4210112

LP-IPS–BASED RISK STRATIFICATION IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA: A NINE-CENTRE TURKISH COHORT

EHA Library, Taner Tan, 4210113

NIVOLUMAB IN FIRST-LINE THERAPY FOR THRLBCL-LIKE PATTERN OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA

EHA Library, Elena Dorokhina, 4210115

OUTCOMES OF PEDIATRIC HODGKIN LYMPHOMA PATIENTS TREATED WITH ABVD REGIMEN. A RETROSPECTIVE COHORT STUDY

EHA Library, Hani Abdel Rahman Sayed, 4210116

SPATIAL TRANSCRIPTOMICS OF THE HODGKIN LYMPHOMA MICROENVIRONMENT: TAM CLUSTERS AND IMMUNE CHECKPOINTS

EHA Library, Lily Filatova, 4210117

AHOD2131: A RANDOMIZED PHASE 3 INTERIM RESPONSE ADAPTED TRIAL COMPARING STANDARD THERAPY WITH IMMUNO-ONCOLOGY THERAPY FOR CHILDREN AND ADULTS WITH NEWLY DIAGNOSED STAGE I/II CLASSIC HODGKIN LYMPHOMA.

EHA Library, Boyu Hu, 4210118

PROGNOSTIC IMPACT OF THE SIMPLIFIED GERIATRIC ASSESSMENT IN OLDER PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA

EHA Library, Vittorio Ruggero Zilioli, 4210119

OPTIMIZATION OF FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA: EFFICACY AND TOXICITY OF N-AVD COMPARED WITH EBEACOPP IN PROSPECTIVE CLINICAL TRIAL. REAL CLINICAL PRACTICE

EHA Library, Diana Ivanova, 4210120

FIRST-LINE NIVOLUMAB-AVD FOR EARLY-STAGE UNFAVORABLE AND ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: A META-ANALYSIS

EHA Library, Fernando Gibran-Nunes, 4210121

PEGYLATED LIPOSOMAL DOXORUBICIN IN HEAVILY PRETREATED ADULT PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: REAL-WORLD DATA FROM GUSTAVE ROUSSY COHORT

EHA Library, CRISTINA GACIA HERCE, 4210122

SARCOPENIA IN OLDER PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: PROGNOSTIC AND TOXICITY-RELATED IMPACT IN A REAL-WORLD COHORT

EHA Library, Silvia Ferrari, 4210123

PROGNOSTIC UTILITY OF THE C-REACTIVE PROTEIN– ALBUMIN–LYMPHOCYTE (CALLY) INDEX IN HODGKIN LYMPHOMA

EHA Library, fatma keklik karadag, 4210124

IMPACT OF CLINICAL TRIAL ELIGIBILITY ON SURVIVAL IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA

EHA Library, Tayfur Toptas, 4210125

CHARACTERISTICS OF MICROSATELLITE INSTABILITY IN NODULAR SCLEROSIS CLASSICAL HODGKIN LYMPHOMA

EHA Library, Dmitry Diakonov, 4210126

INFLAMMATION-BASED SCORES AND THEIR DYNAMIC CHANGES AS PROGNOSTIC INDICATORS IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Hakki Onur Kirkizlar, 4210127

INDIVIDUALIZED MANAGEMENT OF RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A RESOURCE-LIMITED SETTING: A SINGLE-CENTER UKRAINIAN EXPERIENCE

EHA Library, Anisiia Luchkiv, 4210128

INTERIM AND END-OF-TREATMENT (EOT) PET/CT ASSESSMENT AFTER NIVOLUMAB, DOXORUBICIN, VINBLASTINE, AND DACARBAZINE (N-AVD) IN ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA (CHL): A SINGLE-CENTER EXPERIENCE

EHA Library, Alexia Piperidou, 4210129

DIMINISHED PROGNOSTIC VALUE OF INTERIM PET IN HODGKIN LYMPHOMA TREATED WITH BRENTUXIMAB VEDOTIN PLUS AVD: A RETROSPECTIVE ANALYSIS

EHA Library, Kareem Latif, 4210131

PET GUIDED TREATMENT FOR NEWLY DIAGNOSED ADVANCED HODGKIN LYMPHOMA

EHA Library, Fatima Lamraoui, 4210132

A REAL-WORLD ANALYSIS OF FIRST LINE NIVOLUMAB COMBINED WITH DOXORUBICIN, VINBLASTINE, AND DACARBAZINE (N-AVD) IN CLASSICAL HODGKIN LYMPHOMA (CHL) – A SINGLE CENTER COHORT STUDY

EHA Library, Liat Shargian, 4210133

BRENTUXIMAB VEDOTIN-BASED THERAPY FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA IN CHINA: A REAL-WORLD, MULTICENTER ANALYSIS

EHA Library, Nan Zhong, 4210134

REAL-WORLD CLINICAL CHARACTERISTICS, TREATMENT PATTERNS AND OUTCOMES OF CLASSICAL HODGKIN LYMPHOMA IN A MULTI-ETHNIC ASIAN POPULATION: A 15-YEAR SINGLE-CENTRE EXPERIENCE

EHA Library, Roni Wang, 4210135

IMPACT OF INTERIM PET/CT AND DISEASE STAGING ON PROGRESSION AND TREATMENT TRAJECTORIES IN HODGKIN LYMPHOMA: A SINGLE CENTER COHORT STUDY.

EHA Library, Nikola Lemajic, 4210136

SEVERE AND LIFE-THREATENING POLYMORPHIC CUTANEOUS TOXICITY DURING BEGEV SALVAGE THERAPY FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A 9-CASE SERIES

EHA Library, Habiba Bennesser Alaoui, 4210137

REAL-WORLD TOLERABILITY AND PRELIMINARY ANALISYS OF EFFICACY OF BRECADD IN ADVANCED-STAGE HODGKIN LYMPHOMA: A MULTICENTER BRAZILIAN EXPERIENCE

EHA Library, Talita Silveira, 4210139

PREDICTIVE ROLE OF NEUTROPHIL TO LYMPHOCYTE (NLR) AND PLATELET TO LYMPHOCYTE RATIO (PLR) IN NEWLY DIAGNOSED HODGKIN LYMPHOMA

EHA Library, Andrijana Kojic, 4210140

THERAPEUTIC EFFICACY AND SAFETY OF THE TUNISIAN NATIONAL LH 2015 PROTOCOL FOR HODGKIN LYMPHOMA: A 9-YEAR RETROSPECTIVE MONOCENTRIC STUDY

EHA Library, Nesrine Ben Sayed, 4210142

FRONTLINE ABVD IS STILL FEASIBLE IN ADVANCED STAGE HODGKIN LYMPHOMA AS EARLY STAGE: A RETROSPECTIVE REAL-WORLD COHORT STUDY FROM TURKEY

EHA Library, Derya Demirtas, 4210143

THERAPEUTIC OUTCOMES OF ABVD VERSUS ESCALATED BEACOPP IN BULKY MEDIASTINAL HODGKIN LYMPHOMA: A SINGLE-CENTER TUNISIAN EXPERIENCE

EHA Library, Khouloud Mezghani, 4210144

HIGH DISCORDANCE BETWEEN CT AND PET ALTERS THERAPEUTIC STRATEGY IN HIGH-RISK HODGKIN LYMPHOMA: EVIDENCE FROM A PET-GUIDED REAL-WORLD COHORT

EHA Library, Nesrine Ben Sayed, 4210145

REFRACTORY/RELAPSED HODGKIN LYMPHOMA IN CHILDREN: EXPERIENCE OF THE PEDIATRIC CLINICAL HEMATOLOGY DEPARTMENT AT AZIZA OTHMANA HOSPITAL

EHA Library, Lamia Issaoui, 4210146

CLINICAL PROFILE, MANAGEMENT, AND EARLY OUTCOMES OF CLASSICAL HODGKIN LYMPHOMA: A REAL-WORLD DATA FROM A SINGLE-CENTER SERIES (2019–2024)

EHA Library, Malek Benakli, 4210147

THE USE OF PEMBROLIZUMAB AS MONOTHERAPY AND IN COMBINATION WITH CHEMOTHERAPY IN THE TREATMENT OF RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Bibigaisha Adusheva, 4210148

ANALYSIS OF THIRD-LINE TREATMENT OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA FOLLOWING FRONTLINE BENDAMUSTINE/RITUXIMAB AND SECOND-LINE BTK INHIBITOR THERAPY

EHA Library, Christine Ryan, 4210149

REAL-WORLD EFFECTIVENESS AND SAFETY OF ZANUBRUTINIB IN WALDENSTRÖM MACROGLOBULINEMIA: RESULTS FROM THE BELGIAN WIZARD STUDY

EHA Library, Willem Daneels, 4210150

RETREATMENT IN PATIENTS WITH MANTLE CELL LYMPHOMA: A SWEDISH LYMPHOMA REGISTER STUDY

EHA Library, Sandra Lockmer, 4210151

TREATMENT OF HIGH-RISK WALDENSTRÖM MACROGLOBULINEMIA IN PATIENTS OVER 65 YEARS OF AGE

EHA Library, Alexander Grachev, 4210152

BREAST IMPLANT–ASSOCIATED LYMPHOMA: SURFACE TEXTURE AND SURVIVAL OUTCOMES IN A TEN-YEAR SYSTEMATIC REVIEW

EHA Library, KALYSTA BORGES, 4210153

EFFICACY AND SAFETY OF NEMTABRUTINIB IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: COHORT G OF THE PHASE 2 BELLWAVE-003 STUDY

EHA Library, Wojciech Jurczak, 4210154

INTENSIFICATION OF THERAPY FOR WALDENSTRÖM'S MACROGLOBULINEMIA IN PATIENTS UNDER 65 YEARS OF AGE WITH UNFAVORABLE PROGNOSTIC FACTORS

EHA Library, Alexander Grachev, 4210155

MRD-DRIVEN TRIPLET THERAPY WITH ORELABRUTINIB, POMALIDOMIDE, AND ZUBERITAMAB FOR NEWLY DIAGNOSED INTERMEDIATE/HIGH-RISK MANTLE CELL LYMPHOMA

EHA Library, Ping Yang, 4210156

REAL-WORLD OUTCOMES OF BISPECIFIC ANTIBODIES IN OLDER PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

EHA Library, Jessica Allen, 4210157

QUALITY OF LIFE OUTCOMES WITH TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): RESULTS FROM THE PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED INMIND STUDY

EHA Library, Paolo Strati, 4210158

BRIDGING GAPS IN MANTLE CELL LYMPHOMA (MCL) MANAGEMENT: COMPARISON OFCOVALENT BTK INHIBITOR (CBTKI) USAGE AMONG EXPERTS AND HEALTHCARE PROFESSIONALS (HCPS)

EHA Library, Kemi Obajimi, 4210159

TREATMENT PATTERNS AND CLINICAL OUTCOMES IN CNS INVOLVEMENT OF MANTLE CELL LYMPHOMA (MCL) WITH PRIOR BTK INHIBITOR EXPOSURE; AN INTERNATIONAL RETROSPECTIVE STUDY.

EHA Library, Chan Y. Cheah, 4210160